Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease

• Main Authors: M. V. Zhuravleva (Author), G. V. Kukushkin (Author), E. V. Luchinina (Author), T. V. Shelekhova (Author), T. R. Kameneva (Author), E. V. Kuznetsova (Author), E. A. Luchinin (Author)
• Format: Book
• Published: Izdatelstvo OKI, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Relevance. Ademetionine is a hepatoprotective drug, is included in the  draft Russian clinical guidelines for the  diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) and in the  clinical guidelines for treating intrahepatic cholestasis (ITH), the cost analysis of treating patients...